Medical devices are becoming the latest equipment to utilize the Internet to collect data and to send alerts. Here ‘smart inhalers’ are leading the way, with the first commercial units expected within a year. We take a look at the latest developments.
The long anticipated age of the stem cell is upon us. Temcell prevents organ transplants attacking their hosts but will be followed by therapies for more common problems.
Researchers have discovered breaks in nerve cells tied to varous genetically related neurological disorders.
Scientists now have a pill to control the Hulk size tempers.
AN ANGER pill that could even calm down ‘The Incredible Hulk’ may be on the horizon after scientists identified the rage centre of the brain.
I do know that a certain form of Glioblastoma does run in families; however, 3 sisters and all so young is a tragedy.
BONITA SPRINGS, Florida — A Florida family is remembering another child whose life was taken too soon.
Ten-year-old Isabella Mading died on Saturday, February 6th after her year-long battle with a rare form of brain cancer — the same disease that killed her older brother in 2010 and her older sister 2013.
Hmmm; sounds like he needs to read one of my postings on congitive thinking.
Sex, drugs, God, and a hit TV show. Are there any limits to the techno-optimism of television’s favorite “wonder junkie”?
Unity Biotechnology today announced that it is developing medicines to treat and eliminate age-related diseases and increase healthspan, or the amount of time an individual lives in good health.
BrewLife on behalf of Unity Biotechnology.
For the first time, scientists have shown that mitochondria — the “powerhouses” of cells — are crucial for aging, after finding that removing mitochondria from human cells reduced levels of markers for cellular aging, triggering a process of rejuvenation.
More info: http://ow.ly/Y5CcB
This week, Kathy Niakan, a biologist working at the Francis Crick Institute in London received the green light from the UK’s Human Fertilisation and Embryology Authority to use genome editing technique CRISPR/Cas9 on human embryos.
Niakan hopes to answer important questions about how healthy human embryos develop from a single cell to around 250 cells, in the first seven days after fertilization.
By removing certain genes during this early development phase using CRISPR/Cas9, Niakan and her team hope to understand what causes miscarriages and infertility, and in the future, possibly improve the effectiveness of in-vitro fertilization and provide better treatments for infertility.
